Medscape Conference Coverage, based on selected sessions at the:
National Foundation for Infectious Diseases (NFID) 2008 Annual Conference on Antimicrobial Resistance
June 23 - 25, 2008, Bethesda, Maryland
This activity is not sanctioned by, nor a part of, the National Foundation for Infectious Diseases. Conference news does not receive grant support and is produced independently.
Mupirocin Resistance May Be Common in MRSA Clinical IsolatesA survey showed a relatively high rate of mupirocin resistance, and a second study showed increasing resistance to ciprofloxacin among E coli isolates despite targeted interventions.
The materials presented here do not reflect the views of Medscape or the companies providing unrestricted educational grants. These materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. All readers or continuing education participants should verify all information and data before treating patients or employing any therapies described in this educational activity.
The materials presented here were prepared by independent authors under the editorial supervision of Medscape and do not represent a publication of the National Foundation for Infectious Diseases. These materials and the related activity are not sanctioned by the National Foundation for Infectious Diseases or the commercial supporter of the conference and do not constitute an official part of that conference.
